2 hours ago
Cocoa flavanols can be helpful over a brief period, but after 2 years there is little benefit to risk of age-related macular degeneration.
4 hours ago
Poon discussed a community health needs survey and how the “model minority” myth can impact care for Asian Americans.
5 hours ago
Regulatory approval of inebilizumab for immunoglobulin G4-related disease (IgG4-RD) marks the first and only available treatment for adults.
7 hours ago
These findings, while reassuring for JAK inhibitor prescription, nonetheless suggest that VTE-related recommendations for prescriptions should be maintained.
8 hours ago
Q1 2025 allergy updates: FDA approved the first omalizumab biosimilar, and experts shared insights on peanut immunotherapy and food allergy treatments.